Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Paddle leads for the treatment of nonsurgical back pain—The DISTINCT study
Falowski, Steven , Dorsi, Michael J. , Heros, Robert , Sales, Rafe, Tavel, Edward, Lansford, Todd, Weinand, Martin , Baxi, Nrupen , Garber, Jason E., Forage, James, Telfeian, Albert E. , Souheil, Haddad, Gilligan, Christopher , Levy, Robert M. , Jameson, Jessica , Moeschler, Susan M. , Duncan, Jonathan, Lim, Chi, Pilitsis, Julie G. , Okaro, Udoka , Yue, James J. , Deer, Tim , Moeschler, Susan, Desai, Mehul , Okaro, Udoka , Deer, Timothy R. , Duncan, Jonathan

Pain Practice | April 23, 2025 | Volume: 25 | Issue: 5 | Pages: No page available

10.1111/papr.70033 | PMID 40265260 Get It

Abstract Introduction DISTINCT is a randomized controlled trial evaluating passive recharge burst SCS compared with CMM in improving pain and pain‐related physical function in patients suffering from chronic back pain without prior lumbar surgery, and for whom corrective surgery is not an option. Sub‐analyses of outcome measures are presented for a subset implanted with paddle leads at both 6 and 12 months. Objective To investigate the treatment effect of using BurstDR‐capable SCS in nonsurgical low back pain (NSLBP) patients with paddle leads. Methods An independent board‐certified spine surgeon reviewed each case, confirming a lack of corrective surgical options. Out of 29 sites and 115 implants, 10 sites implanted 50 patients with paddle leads. Primary and secondary endpoints assessed improvements in low back pain intensity (NRS), low back pain‐related disability (ODI), pain catastrophizing (PCS), and patient global impression of change (PGIC). Results Data for patients with NSLBP and implanted with paddle leads are available for 47 and 44 patients at 6 and 12 months, respectively. Patients reported significant reductions in pain relief at 6 and 12 months, decreasing from 7.8 ± 1.2 at baseline to 2.0 ± 1.6 and 2.2 ± 2.2, respectively ( p < 0.0001). Disability was substantially reduced (> 20 points) from severe to mild at 6 and 12 months; ODI reduced from 54.4 ± 15.0 at baseline to 19.9 ± 14.1 and 22.1 ± 13.6, respectively ( p < 0.0001). Pain catastrophizing improved to reflect the average of a non‐chronic pain population; decreased from 27.6 ± 13.1 at baseline to 8.1 ± 8.2 and 7.8 ± 9.9 ( p < 0.0001). 93.2% of patients reported a moderately better‐much‐improved outcome on PGIC. Ten complications occurred in 9 patients, 3 being severe device‐related events. Two explants were required; one due to infection and one due to persistent pain at the IPG site, and one lead‐related event was resolved by surgical repositioning. Conclusions Passive recharge burst using paddle leads provides substantial relief to patients suffering from severe, debilitating, NSLBP. Patients report significant improvements in pain, function, and pain‐related emotional distress. In addition, the rate of adverse events is low, supporting a favorable safety profile.
Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy
Trinka, Eugen , Wirrell, Elaine , Abdulla, Fatema , Albaradie, Raidah , Auvin, Stéphane , Singh, Mamta Bhushan , Blumenfeld, Hal , Fressola, Alicia Bogacz , Caraballo, Roberto , Charway‐Felli, Augustina , Ezeala‐Adikaibe, Birinus , Gule, M. V., Higurashi, Norimichi , Jansen, Floor E. , Kahane, Philippe , Vinayan, Kollencheri Puthenveettil , Lagae, Lieven , Lim, Kheng Seang , Lizcano, Angélica , McGonigal, Aileen , Perez‐Gosiengfiao, Katerina Tanya, Ryvlin, Philippe , Stefan, H. , Tatum, William O. , Tripathi, Manjari, Yacubian, Elza Márcia Targas , Wiebe, Samuel , Wilmshurst, Jo M. , Zhou, Dong , Cross, J. Helen , Beniczky, Sándor , Trinka, Eugen , Wirrell, Elaine C , Al Baradie, Raidah , Auvin, Stéphane , Singh, Mamta Bhushan , Blumenfeld, Hal , Bogacz Fressola, Alicia , Caraballo, Roberto H , Cendes, Fernando , Felli, Augustina Charway , Cook, Mark J , Craiu, Dana , Frauscher, Birgit , French, Jacqueline , Higurashi, Norimichi , Ikeda, Akio , Jansen, Floor E , Jobst, Barbara , Kahane, Philippe , Kishk, Nirmeen , Khoo, Ching Soong , Lagae, Lieven , Lim, Kheng-Seang , Lizcano, Angelica , McGonigal, Aileen , Ryvlin, Philippe , Specchio, Nicola , Sperling, Michael R , Tatum, William O , Yacubian, Elza Márcia , Wiebe, Samuel , Wilmshurst, Jo M , Zhou, Dong , Cross, Helen J , Alonso‐Vanegas, Mario , Carreño, Mar , Cendes, Fernando , Cook, Mark , Frauscher, Birgit , French, Jacqueline A. , Jobst, Barbara C. , Specchio, Nicola , Sperling, Michael R. , Tripathi, Manjari

Epilepsia | April 23, 2025 | Volume: 66 | Issue: 6 | Pages: 1804-1823

10.1111/epi.18338 | PMID 40264351 Get It

Abstract The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework established in 2017. This revision, informed by the implementation experience, involved a working group appointed by the ILAE Executive Committee. Comprising 37 members from all ILAE regions, the group utilized a modified Delphi process, requiring a consensus threshold of more than two thirds for any proposal. Following public comments, the Executive Committee appointed seven additional experts to the revision task force to address and incorporate the issues raised, as appropriate. The updated classification maintains four main seizure classes: Focal, Generalized, Unknown (whether focal or generalized), and Unclassified. Taxonomic rules distinguish classifiers, which are considered to reflect biological classes and directly impact clinical management, from descriptors, which indicate other important seizure characteristics. Focal seizures and those of unknown origin are further classified by the patient's state of consciousness (impaired or preserved) during the seizure, defined operationally through clinical assessment of awareness and responsiveness. If the state of consciousness is undetermined, the seizure is classified under the parent term, that is, the main seizure class (focal seizure or seizure of unknown origin). Generalized seizures are grouped into absence seizures, generalized tonic–clonic seizures, and other generalized seizures, now including recognition of negative myoclonus as a seizure type. Seizures are described in the basic version as with or without observable manifestations, whereas an expanded version utilizes the chronological sequence of seizure semiology. This updated classification comprises four main classes and 21 seizure types. Special emphasis was placed on ensuring translatability into languages beyond English. Its aim is to establish a common language for all health care professionals involved in epilepsy care, from resource‐limited areas to highly specialized centers, and to provide accessible terms for patients and caregivers.
Pulley Reconstruction for Bowstringing After Gracilis Free Functioning Muscle Transfer for Elbow Flexion in Adult Traumatic Brachial Plexus Injury
Lee, Ellen Y. , Spinner, Robert J., Bishop, Allen T. , Spinner, Robert J. , Shin, Alexander Y.

Techniques in Hand & Upper Extremity Surgery | April 23, 2025 | Volume: 29 | Issue: 3 | Pages: No page available

10.1097/bth.0000000000000516 | PMID 40263975 Get It

The gracilis free functioning muscle transfer is an established procedure for reconstructing elbow, wrist, and hand function in adult traumatic brachial plexus injury patients. Elbow flexion or distal wrist or hand function can be compromised by gracilis bowstringing in up to 17.8% of patients. Two techniques for pulley reconstruction to correct bowstringing and improve the function of the gracilis transfer are described.
Updating the ILAE seizure classification
Trinka, Eugen , Wirrell, Elaine , Cendes, Fernando , Cross, J. Helen , Beniczky, Sándor , Trinka, Eugen , Wirrell, Elaine C , Specchio, Nicola , Cendes, Fernando , Cross, Helen J , Specchio, Nicola

Epilepsia | April 23, 2025 | Volume: 66 | Issue: 6 | Pages: 1824-1826

10.1111/epi.18399 | PMID 40264360 Get It

Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA ® ) administered by colonoscopy for prevention of recurrent Clostridioides difficile infectio
Khanna, Sahil , Yoho, David, Handel, Daniel Van, Clark, Brian J., Awad, Tahany , Guthmueller, Beth, Armandi, Daniel, Knapple, W , Safdar, Nasia , Baggott, Brian, Simon, Karen, Knapple, Whitfield , Feuerstadt, Paul , Feuerstadt, Paul

Therapeutic Advances in Gastroenterology | April 23, 2025 | Volume: 18 | Issue: No issue available | Pages: No page available

10.1177/17562848251339697 | PMID 40321366 Get It

Background: Recurrent Clostridioides difficile infection (rCDI) occurs in up to 35% of patients with CDI, and further recurrence is common. Fecal microbiota, live-jslm (RBL) is safe and effective for preventing rCDI in adults following antibiotic treatment for rCDI when administered rectally. There is clinical interest in alternative routes of administration. Objectives: CDI-SCOPE assessed the safety and clinical effectiveness of RBL when administered via colonoscopy to adults with rCDI. Design: Single-arm, exploratory phase IIIb trial conducted at 12 sites in the United States. Methods: Eligible adults with rCDI received one administration of RBL consisting of one 150-mL dose of RBL, delivered via colonoscopy to the right side of the colon. The primary endpoint assessed RBL-related treatment-emergent adverse events (TEAEs) within 8 weeks of RBL administration or until confirmed treatment failure. Secondary endpoints included treatment success (absence of CDI recurrence for 8 weeks following RBL administration), physician experience administering RBL via colonoscopy, and physician perception of participant benefit. Results: Of 54 participants screened, 41 were enrolled and received RBL via colonoscopy; 39 participants completed the 8-week visit. Five TEAEs in four participants (9.8%) were assessed as related to RBL, all of which were gastrointestinal and mild in severity. Overall, 18 participants (43.9%) experienced 33 TEAEs within 8 weeks, most of which were of mild (25/33; 75.8%) or moderate (5/33; 15.2%) severity. No TEAEs led to intensive care unit admission or death. Overall, 39 participants (95.1%) experienced treatment success; 2 participants (4.9%) withdrew consent and had an indeterminate outcome. Among physicians, 90.2% of investigators indicated a “positive” or “very positive” experience administering RBL by colonoscopy. All physicians assessed participant benefit as “much” or “very much” improved. Conclusion: This single-arm study suggests RBL administered via colonoscopy is practical, safe, and effective for preventing CDI recurrence following antibiotic treatment in adults. Trial registration: ClinicalTrials.gov: NCT05831189.
Survival and Chemotherapy Response in Metastatic Lung Carcinoids: Insights from the National Cancer Database
Neupane, Niraj , Yadav, Sumeet Kumar, Houle, Scott R., Ghimire, Umesh , Neupane, Binita , Thapa, Sangharsha, Kharel, Zeni , Niu, Chengu , Joshi, Utsav , Ghaffary, Elham Moases , Houle, Scott R., Thapa, Sangharsha , Mirmosayyeb, Omid

Hematology/Oncology and Stem Cell Therapy | April 23, 2025 | Volume: 18 | Issue: 1 | Pages: 14-20

10.4103/hemoncstem.hemoncstem-d-24-00001 | PMID 40263899 Get It

Background : Metastatic lung carcinoids (MLCs) represent a rare subset of lung cancers with distinct histologic subtypes. Survival outcomes and prognostic factors have not been well-studied in the real-world setting. This study investigates the impact of various treatments, including chemotherapy, hormonal therapy, and no treatment, on the overall survival (OS) of patients with typical and atypical MLC. Methods: Patients with MLC between 2010 and 2020 were included from the National Cancer Database based on histologic codes ICD-O-3 8240/3 and 8249/3. Kaplan–Meier curves and multivariate Cox proportional hazard regression were used to compare OS and evaluate prognostic factors. Results: The median age at diagnosis was 68 and 69 years for atypical and typical MLC, respectively. The 3-year OS for the atypical MLC cohort was 22.11%, and for typical MLC was 41.94% ( P < 0.001). In the atypical MLC cohort, chemotherapy showed a nonsignificant benefit in OS (hazard ratio [HR], 0.89; 95% confidence interval [CI], 0.73–1.05; P = 0.21), whereas hormonal therapy was associated with significantly improved OS (HR, 0.72; 95% CI, 0.52–0.98; P =0.04). However, in the typical MLC cohort, chemotherapy was associated with adverse OS (HR, 2.15; 95% CI, 1.85–2.49; P < 0.0001), and hormonal treatment showed better, albeit nonsignificant OS (HR, 0.84; 95% CI, 0.67–1.05; P = 0.13). Conclusion: There is a notable difference in survival outcomes between typical and atypical MLC based on the treatment strategies. While hormonal therapy shows improvement in the OS, the effectiveness of chemotherapy varies depending on the histologic subtype. These findings emphasize the necessity for personalized therapeutic approaches based on the specific characteristics of MLC, ultimately contributing to improved patient outcomes in this challenging oncologic group. Further research is warranted to validate and expand upon these observations.
Tumor Landscape Analysis: An Ecologically Informed Framework to Understand Tumor Microenvironments
Cisneros, Luis , Fernández-Zapico, Martín E. , Maley, Carlo C. , Carr, Ryan M. , Maley, Carlo C. , Cisneros, Luis H , Carr, Ryan M , Toruner, Merih Deniz

No container title available | April 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.04.22.646608 Get It

Abstract Tumor microenvironments (TMEs) are spatially complex and dynamic systems shaped by evolutionary pressures, tissue architecture, and cellular interactions. To capture this complexity, we developed the Tumor Landscape Analysis (TLA) pipeline, a computational framework applying principles from landscape ecology and spatial statistics to quantitatively characterize tumor spatial heterogeneity. TLA integrates spatially resolved pathology data, including whole-cell, point-based, and region-level formats, and computes multiscale metrics to assess cell distributions, neighborhood relationships, and tissue-level organization. The framework leverages ecological indices such as the Morisita-Horn index, Ripley’s H function, and Shannon diversity to quantify intercellular proximity, spatial clustering, and cellular diversity. It also uses the concept of local microenvironments (LMEs), data-driven ecological niches defined by local cell-type abundance and spatial uniformity, enabling unsupervised and reproducible classification of tumor regions. The use of fragmentation metrics, including patch density, shape complexity, and interspersion, provide further insight into spatial disorganization and emergent tissue architecture. TLA is agnostic to imaging modality and biological context, supporting broad applicability across tumor types and sample formats. By translating complex tissue architectures into interpretable spatial metrics, the pipeline enables integrative analyses that link spatial ecology to clinical and molecular phenotypes. This approach facilitates a deeper understanding of how spatial features contribute to tumor progression, therapeutic resistance, and clinical outcomes, offering new opportunities for precision oncology rooted in spatial systems biology.
Current Diagnostics and management of submandibular space schwannoma: a systematic review
Vasudevan, Srivatsa Surya , Caballero, Anyull D. Bohorquez, Kandrikar, Tiba Yamin , Janus, Jeffrey R. , Candelo, Estephanía , Bohorquez Caballero, Anyull D, Green, Katerina J. , Janus, Jeffrey R , Caballero, Anyull D. Bohorquez, Green, Katerina

Acta Oto-Laryngologica | April 23, 2025 | Volume: 145 | Issue: 6 | Pages: 545-553

10.1080/00016489.2025.2486611 | PMID 40262932 Get It

Rare Extra‐Axial Chordoma of the Anteromedial Thigh: A Case Report
Tibbo, Meagan E. , Mysore, Nishad , Jose, Jean , Temple, H. Thomas , Rosenberg, Andrew E.

Clinical Case Reports | April 23, 2025 | Volume: 13 | Issue: 4 | Pages: No page available

10.1002/ccr3.70341 | PMID 40270777 Get It

ABSTRACT Chordomas are rare notochordal malignancies typically occurring in the axial skeleton. Less than 100 extra‐axial chordomas have been reported. We describe a unique chordoma of the anteromedial thigh. The clinical presentation of extra‐axial chordomas is highly variable; thus, recognizing this entity in the differential diagnoses of extra‐axial bone/soft tissue tumors is important.
Reply to Singh et al.
Vantanasiri, Kornpong , Iyer, Prasad G.

Endoscopy | April 22, 2025 | Volume: 57 | Issue: 05 | Pages: 571-572

10.1055/a-2511-1951 | PMID 40262589 Get It